Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $310.0000 (6.16%) ($270.2500 - $340.0500) on Mon. Feb. 14, 2011. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.35% (three month average) | RSI | 69 | Latest Price | $310.0000(6.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.7% a day on average for past five trading days. | Weekly Trend | CAPR advances 2.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(4%) IWM(3%) XOP(3%) EWI(2%) EWP(2%) | Factors Impacting CAPR price | CAPR will decline at least -3.175% in a week (0% probabilities). REMX(-1%) IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.175% (StdDev 6.35%) | Hourly BBV | 0 () | Intraday Trend | 6% | | | |
|
5 Day Moving Average | $288.46(7.47%) | 10 Day Moving Average | $288.13(7.59%) | 20 Day Moving Average | $282.61(9.69%) | To recent high | -6.1% | To recent low | 40.9% | Market Cap | $6.106b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |